Authors:
AKAMINE S
KATAYAMA Y
HIGENBOTTAM T
LOCK T
Citation: S. Akamine et al., DEVELOPMENTS IN INHALED IMMUNOSUPPRESSIVE THERAPY FOR THE PREVENTION OF PULMONARY GRAFT-REJECTION, Biodrugs, 9(1), 1998, pp. 49-59
Citation: Sj. Lynn et al., DETERMINANTS OF PSEUDOMEMORIES - CLINICAL AND FORENSIC IMPLICATIONS, International journal of clinical and experimental hypnosis, 45(4), 1997, pp. 470-471
Authors:
NELSON F
BILLINGHURST C
REINER A
COLLON D
GOITZ H
LOCK T
IONESCU M
POOLE AR
Citation: F. Nelson et al., INCREASED CLEAVAGE BY COLLAGENASE AND LOSS OF TYPE-II COLLAGEN IN ARTICULAR-CARTILAGE FOLLOWING KNEE INJURY - A LONGITUDINAL-STUDY OF THE DEVELOPMENT OF CARTILAGE DEGENERATION IN HUMAN OSTEOARTHROSIS, Arthritis and rheumatism, 40(9), 1997, pp. 922-922
Citation: Ga. Konrath et al., THE USE OF COLD THERAPY AFTER ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION - A PROSPECTIVE, RANDOMIZED STUDY AND LITERATURE-REVIEW, American journal of sports medicine, 24(5), 1996, pp. 629-633
Authors:
PERRY S
HARRIES H
SCHOLFIELD C
LOCK T
KING L
GIBSON G
GOLDFARB P
Citation: S. Perry et al., MOLECULAR-CLONING AND EXPRESSION OF A CDNA FOR HUMAN KIDNEY CYSTEINE CONJUGATE BETA-LYASE, FEBS letters, 360(3), 1995, pp. 277-280
Authors:
KATONA CLE
ABOUSALEH MT
HARRISON DA
NAIRAC BA
EDWARDS DRL
LOCK T
BURNS RA
ROBERTSON MM
Citation: Cle. Katona et al., PLACEBO-CONTROLLED TRIAL OF LITHIUM AUGMENTATION OF FLUOXETINE AND LOFEPRAMINE, British Journal of Psychiatry, 166, 1995, pp. 80-86
Authors:
KATONA CLE
ABOUSALEH MT
HARRISON DA
NAIRAC BA
EDWARDS DRL
LOCK T
BURNS RA
ROBERTSON MN
Citation: Cle. Katona et al., PLACEBO-CONTROLLED TRIAL OF LITHIUM AUGMENTATION OF FLUOXETINE AND LOFEPRAMINE (VOL 166, PG 80, 1995), British Journal of Psychiatry, 166, 1995, pp. 544-544
Authors:
LAWRENCE KM
KATONA CLE
ABOUSALEH MT
ROBERTSON MM
NAIRAC BL
EDWARDS DRL
LOCK T
BURNS RA
HARRISON DA
HORTON RW
Citation: Km. Lawrence et al., PLATELET 5-HT UPTAKE SITES, LABELED WITH [H-3] PAROXETINE, IN CONTROLS AND DEPRESSED-PATIENTS BEFORE AND AFTER TREATMENT WITH FLUOXETINE ORLOFEPRAMINE, Psychopharmacology, 115(1-2), 1994, pp. 261-264
Authors:
EDWARDS DRL
LOCK T
KATONA CLE
ABOUSALEH MT
BURNS RA
NAIRAC BL
HARRISON D
ROBERTSON MM
Citation: Drl. Edwards et al., PARTIALLY-SIGHTED - INVESTIGATOR GUESSES IN A DOUBLE-BLIND CONTROLLEDTRIAL, International journal of methods in psychiatric research, 4(1), 1994, pp. 7-11
Authors:
BARBOSA S
BLUMHARDT LD
ROBERTS N
LOCK T
EDWARDS RHT
Citation: S. Barbosa et al., MAGNETIC-RESONANCE RELAXATION-TIME MAPPING IN MULTIPLE-SCLEROSIS - NORMAL APPEARING WHITE-MATTER AND THE INVISIBLE LESION LOAD, Magnetic resonance imaging, 12(1), 1994, pp. 33-42
Authors:
ROBERTSON MM
ABOUSALEH MT
HARRISON DA
NAIRAC BL
EDWARDS DRL
LOCK T
BURNS RA
KATONA CLE
Citation: Mm. Robertson et al., A DOUBLE-BLIND CONTROLLED COMPARISON OF FLUOXETINE AND LOFEPRAMINE INMAJOR DEPRESSIVE-ILLNESS, J PSYCHOPH, 8(2), 1994, pp. 98-103
Authors:
SILVERSTONE T
ABOUSALEH MT
PATHAK R
LOCK T
BENNIE E
MOHAMMED Y
CHAKRAVARTI SK
JAUHAR P
KATONA C
SHAMASH K
KHAN MC
LIVINGSTON M
CAHILL C
SHARMA VK
SINGH V
COOKSON J
SIRELING LI
MORGAN J
SURI AK
Citation: T. Silverstone et al., A MULTICENTER COMPARATIVE TRIAL OF MOCLOBEMIDE, IMIPRAMINE AND PLACEBO IN MAJOR DEPRESSIVE DISORDER, International clinical psychopharmacology, 9(2), 1994, pp. 109-113
Authors:
KATONA CL
ROBERTSON MM
ABOUSALEH MT
NAIRAC BL
EDWARDS DR
LOCK T
BURNS R
HARRISON DA
TAYLOR NS
Citation: Cl. Katona et al., PLACEBO-CONTROLLED TRIAL OF LITHIUM AUGMENTATION OF FLUOXETINE AND LOFEPRAMINE, International clinical psychopharmacology, 8(4), 1993, pp. 323-323